Skip to main content
SpringerLink
Log in

Evaluation of Human Liver Slices and Reporter Gene Assays as Systems for Predicting the Cytochrome P450 Induction Potential of Drugs in Vivo in Humans

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Purpose

The aim of the study was to investigate the feasibility of predicting human in vivo cytochrome P450 (CYP) induction properties of drugs using in vitro methods.

Methods

The CYP induction potential of compounds was tested in human liver slices and in reporter gene assays for the aryl hydrocarbon receptor (AhR) and the pregnane X receptor (PXR).

Results

In human liver slices, CYP activities decreased dramatically over the experimental period, whereas mRNA levels could reliably be used to investigate CYP1A, 2C9, and 3A4 induction. However, the interindividual variations and demanding experimentation limit the use of liver slices in screening programs. Reporter gene assays are robust and reliable assays, amenable to high throughput screening. Several compounds activated AhR. The relevance of this activation, however, needs to be further investigated since there are no clear reports on drugs inducing CYP1A in vivo. The results from the PXR assay could be used to correctly classify compounds with known CYP3A induction properties when relating in vivo AUCtot to PXR EC50 values.

Conclusions

Liver slices are a valuable model to study the regulation of a larger number of enzymes by single compounds. The PXR reporter gene assay could be used as a reliable screening method to predict CYP3A induction in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Abbreviations

AhR:

aryl hydrocarbon receptor

CYP:

cytochrome P450

huPO:

human acidic ribosomal phosphoprotein

PXR:

pregnane X receptor

TCDD:

2,3,7,8-tetrachloro-dibenzo-p-dioxin

References

  1. J. T. Backman K. T. Olkkola P. J. Neuvonen (1996) ArticleTitleRifampin drastically reduces plasma concentrations and effects of oral midazolam Clin. Pharmacol. Ther. 59 7–13 Occurrence Handle10.1016/S0009-9236(96)90018-1 Occurrence Handle1:CAS:528:DyaK28Xhtlymsbk%3D Occurrence Handle8549036

    Article  CAS  PubMed  Google Scholar 

  2. L. D. Heimark M. Gibaldi W. F. Trager R. A. O'Reilly D. A. Goulart (1987) ArticleTitleThe mechanism of the warfarin–rifampin drug interaction in humans Clin. Pharmacol. Ther. 42 388–394 Occurrence Handle1:CAS:528:DyaL1cXjtFegsQ%3D%3D Occurrence Handle3665337

    CAS  PubMed  Google Scholar 

  3. D. R. Rutledge J. A. Pieper D. M. Mirvis (1988) ArticleTitleEffects of chronic phenobarbital on verapamil disposition in humans J. Pharmacol. Exp. Ther. 246 7–13 Occurrence Handle1:CAS:528:DyaL1cXkvVGkt7g%3D Occurrence Handle3392664

    CAS  PubMed  Google Scholar 

  4. P. L. Morselli M. Rizzo S. Garattini (1971) ArticleTitleInteraction between phenobarbital and diphenylhydantoin in animals and in epileptic patients Ann. N.Y. Acad. Sci. 179 88–107 Occurrence Handle1:CAS:528:DyaE3MXkvFOhs78%3D Occurrence Handle5285399

    CAS  PubMed  Google Scholar 

  5. T. Prueksaritanont J. M. Vega J. Zhao K. Gagliano O. Kuznetsova B. Musser R. D. Amin L. Liu B. A. Roadcap S. Dilzer K. C. Lasseter J. D. Rogers (2001) ArticleTitleInteractions between simvastatin and troglitazone or pioglitazone in healthy subjects J. Clin. Pharmacol. 41 573–581 Occurrence Handle1:CAS:528:DC%2BD3MXjvVaktrw%3D Occurrence Handle11361054

    CAS  PubMed  Google Scholar 

  6. P. L. M. Giersbergen Particlevan A. Halabi J. Dingemanse (2002) ArticleTitleSingle- and multiple-dose pharmacokinetics of bosentan and its interaction with ketoconazole Br. J. Clin. Pharmacol. 53 589–595 Occurrence Handle12047483

    PubMed  Google Scholar 

  7. G. G. Gibson N. J. Plant K. E. Swales A. Ayrton W. El-Sankary (2002) ArticleTitleReceptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man Xenobiotica 32 165–206 Occurrence Handle10.1080/00498250110102674 Occurrence Handle1:CAS:528:DC%2BD38XivFGhtL0%3D Occurrence Handle11958559

    Article  CAS  PubMed  Google Scholar 

  8. J. M. Lehmann D. D. McKee M. A. Watson T. M. Willson J. T. Moore S. A. Kliewer (1998) ArticleTitleThe human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions J. Clin. Invest. 102 1016–1023 Occurrence Handle1:CAS:528:DyaK1cXlvVCqtLY%3D Occurrence Handle9727070 Occurrence Handle10.1172/JCI3703

    Article  CAS  PubMed  Google Scholar 

  9. Y. Chen S. S. Ferguson M. Negishi J. A. Goldstein (2004) ArticleTitleInduction of human CYP2C9 by rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor J. Pharmacol. Exp. Ther. 308 495–501 Occurrence Handle1:CAS:528:DC%2BD2cXhtlSqtb4%3D Occurrence Handle14600250

    CAS  PubMed  Google Scholar 

  10. J. P. Whitlock SuffixJr (1999) ArticleTitleInduction of cytochrome P4501A1 Annu. Rev. Pharmacol. Toxicol. 39 103–125 Occurrence Handle10.1146/annurev.pharmtox.39.1.103 Occurrence Handle1:CAS:528:DyaK1MXjtVejt70%3D Occurrence Handle10331078

    Article  CAS  PubMed  Google Scholar 

  11. V. H. Black L. C. Quattrochi (2004) ArticleTitleMolecular cloning of the guinea pig CYP1A2 gene 5′-flanking region: identification of functional aromatic hydrocarbon response element and characterization of CYP1A2 expression in GPC16 cells Drug Metab. Dispos. 32 595–602 Occurrence Handle10.1124/dmd.32.6.595 Occurrence Handle1:CAS:528:DC%2BD2cXktlOgtr0%3D Occurrence Handle15155550

    Article  CAS  PubMed  Google Scholar 

  12. M. S. Denison S. R. Nagy (2003) ArticleTitleActivation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals Annu. Rev. Pharmacol. Toxicol. 43 309–334 Occurrence Handle10.1146/annurev.pharmtox.43.100901.135828 Occurrence Handle1:CAS:528:DC%2BD3sXitFWqtr8%3D Occurrence Handle12540743

    Article  CAS  PubMed  Google Scholar 

  13. S. A. Jones L. B. Moore J. L. Shenk G. B. Wisely G. A. Hamilton D. D. McKee N. C. O. Tomkinson E. L. LeCluyse M. H. Lambert T. M. Willson S. A. Kliewer J. T. Moore (2000) ArticleTitleThe pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution Mol. Endocrinol. 14 27–39 Occurrence Handle10.1210/me.14.1.27 Occurrence Handle1:CAS:528:DC%2BD3cXislWjsg%3D%3D Occurrence Handle10628745

    Article  CAS  PubMed  Google Scholar 

  14. L. A. Vignati A. Bogni P. Grossi M. Monshouwer (2004) ArticleTitleA human and mouse pregnane X receptor reporter gene assay in combination with cytotoxicity measurements as a tool to evaluate species-specific CYP3A induction Toxicology 199 23–33 Occurrence Handle10.1016/j.tox.2003.12.018 Occurrence Handle1:CAS:528:DC%2BD2cXjs1Clu74%3D Occurrence Handle15125996

    Article  CAS  PubMed  Google Scholar 

  15. M. Backlund M. Ingelman-Sundberg (2004) ArticleTitleDifferent structural requirements of the ligand binding domain of the aryl hydrocarbon receptor for high- and low-affinity ligand binding and receptor activation Mol. Pharmacol. 65 416–425 Occurrence Handle10.1124/mol.65.2.416 Occurrence Handle1:CAS:528:DC%2BD2cXitFaks7k%3D Occurrence Handle14742684

    Article  CAS  PubMed  Google Scholar 

  16. R. J. Edwards R. J. Price P. S. Watts A. B. Renwick J. M. Tredger A. R. Boobis B. G. Lake (2003) ArticleTitleInduction of cytochrome P450 enzymes in cultured precision-cut human liver slices Drug Metab. Dispos. 31 282–288 Occurrence Handle1:CAS:528:DC%2BD3sXhsFKlt7k%3D Occurrence Handle12584154

    CAS  PubMed  Google Scholar 

  17. W. P. Bowen J. E. Carey A. Miah H. F. McMurray P. W. Munday R. S. James R. A. Coleman A. M. Brown (2000) ArticleTitleMeasurement of cytochrome P450 gene induction in human hepatocytes using quantitative real-time reverse transcriptase–polymerase chain reaction Drug Metab. Dispos. 28 781–788 Occurrence Handle1:CAS:528:DC%2BD3cXks12isL8%3D Occurrence Handle10859152

    CAS  PubMed  Google Scholar 

  18. H. Martin J. P. Sarsat I. Waziers Particlede C. Housset P. Balladur P. Beaune V. Albaladejo C. Lerche-Langrand (2003) ArticleTitleInduction of cytochrome P450 2B6 and 3A4 expression by phenobarbital and cyclophosphamide in cultured human liver slices Pharm. Res. 20 557–568 Occurrence Handle10.1023/A:1023234429596 Occurrence Handle1:CAS:528:DC%2BD3sXivVWksLc%3D Occurrence Handle12739762

    Article  CAS  PubMed  Google Scholar 

  19. B. J. Komoroski S. Zhang H. Cai J. M. Hutzler R. Frye T. S. Tracy S. C. Strom T. Lehmann C. Y. W. Ang Y. Y. Cui R. Venkataramanan (2004) ArticleTitleInduction and inhibition of cytochromes p450 by the St. John's wort constituent hyperforin in human hepatocyte cultures Drug Metab. Dispos. 32 512–518 Occurrence Handle10.1124/dmd.32.5.512 Occurrence Handle1:CAS:528:DC%2BD2cXjs1GrsLk%3D Occurrence Handle15100173

    Article  CAS  PubMed  Google Scholar 

  20. A. Madan R. A. Graham K. M. Carroll D. R. Mudra L. A. Burton L. A. Krueger A. D. Downey M. Czerwinski J. Forster M. D. Ribadeneira L. S. Gan E. L. LeCluyse K. Zech P. Robertson SuffixJr. P. Koch L. Antonian G. Wagner L. Yu A. Parkinson (2003) ArticleTitleEffects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes Drug Metab. Dispos. 31 421–431 Occurrence Handle10.1124/dmd.31.4.421 Occurrence Handle1:CAS:528:DC%2BD3sXisFeitrc%3D Occurrence Handle12642468

    Article  CAS  PubMed  Google Scholar 

  21. A. Berghard K. Gradin I. Pongratz M. Whitelaw L. Poellinger (1993) ArticleTitleCross-coupling of signal transduction pathways: the dioxin receptor mediates induction of cytochrome P-450IA1 expression via a protein kinase C-dependent mechanism Mol. Cell. Biol. 13 677–689 Occurrence Handle1:CAS:528:DyaK3sXps1Sisg%3D%3D Occurrence Handle8380231

    CAS  PubMed  Google Scholar 

  22. B. Goodwin E. Hodgson C. Liddle (1999) ArticleTitleThe orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module Mol. Pharmacol. 56 1329–1339 Occurrence Handle1:CAS:528:DyaK1MXns1yhurw%3D Occurrence Handle10570062

    CAS  PubMed  Google Scholar 

  23. V. Meunier M. Bourrié B. Julian E. Marti F. Guillou Y. Berger G. Fabre (2000) ArticleTitleExpression and induction of CYP1A1/1A2, CYP2A6 and CYP3A4 in primary cultures of human hepatocytes: a 10-year follow-up Xenobiotica 30 589–607 Occurrence Handle1:CAS:528:DC%2BD3cXkvFClt7k%3D Occurrence Handle10923861

    CAS  PubMed  Google Scholar 

  24. F. Fontaine C. Delescluse G. Sousa Particlede P. Lesca R. Rahmani (1999) ArticleTitleCytochrome 1A1 induction by primaquine in human hepatocytes and HepG2 cells: absence of binding to the aryl hydrocarbon receptor Biochem. Pharmacol. 57 255–262 Occurrence Handle10.1016/S0006-2952(98)00304-9 Occurrence Handle1:CAS:528:DyaK1MXitV2mug%3D%3D Occurrence Handle9890552

    Article  CAS  PubMed  Google Scholar 

  25. K. Na-Bangchang J. Karbwang R. Ubalee A. Thanavibul S. Saenglertsilapachai (2000) ArticleTitleAbsence of significant pharmacokinetic and pharmacodynamic interactions between artemether and quinoline antimalarials Eur. J. Drug Metab. Pharmacokinet. 25 171–178 Occurrence Handle1:CAS:528:DC%2BD3MXktlKlt7w%3D Occurrence Handle11420886

    CAS  PubMed  Google Scholar 

  26. R. Curi-Pedrosa M. Daujat L. Pichard J. C. Ourlin P. Clair L. Gervot P. Lesca J. Domergue H. Joyeux G. Fourtanier P. Maurel (1994) ArticleTitleOmeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture J. Pharmacol. Exp. Ther. 269 384–392 Occurrence Handle1:CAS:528:DyaK2cXkslentLc%3D Occurrence Handle8169844

    CAS  PubMed  Google Scholar 

  27. X. Q. Li T. B. Andersson M. Ahlström L. Weidolf (2004) ArticleTitleComparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities Drug Metab. Dispos. 32 821–827 Occurrence Handle10.1124/dmd.32.8.821 Occurrence Handle1:CAS:528:DC%2BD2cXmtFCjt7Y%3D Occurrence Handle15258107

    Article  CAS  PubMed  Google Scholar 

  28. T. Andersson J. Holmberg K. Röhss A. Walan (1998) ArticleTitlePharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole Br. J. Clin. Pharmacol. 45 369–375 Occurrence Handle1:CAS:528:DyaK1cXisV2nsb4%3D Occurrence Handle9578184 Occurrence Handle10.1046/j.1365-2125.1998.t01-1-00702.x

    Article  CAS  PubMed  Google Scholar 

  29. K. Dilger Z. Zheng U. Klotz (1999) ArticleTitleLack of drug interaction between omeprazole, lansoprazole, pantoprazole and theophylline Br. J. Clin. Pharmacol. 48 438–444 Occurrence Handle10.1046/j.1365-2125.1999.00043.x Occurrence Handle1:CAS:528:DyaK1MXmsFehsb4%3D Occurrence Handle10510158

    Article  CAS  PubMed  Google Scholar 

  30. J. M. Rae M. D. Johnson M. E. Lippman D. A. Flockhart (2001) ArticleTitleRifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays J. Pharmacol. Exp. Ther. 299 849–857 Occurrence Handle1:CAS:528:DC%2BD3MXovVCktr4%3D Occurrence Handle11714868

    CAS  PubMed  Google Scholar 

  31. B. Tomlinson R. P. Young M. C. Y. Ng P. J. Anderson R. Kay J. A. J. H. Critchley (1996) ArticleTitleSelective liver enzyme induction by carbamazepine and phenytoin in Chinese epileptics Eur. J. Clin. Pharmacol. 50 411–415 Occurrence Handle10.1007/s002280050132 Occurrence Handle1:CAS:528:DyaK28Xlt12gtr0%3D Occurrence Handle8839665

    Article  CAS  PubMed  Google Scholar 

  32. M. S. Ching S. L. Elliott C. K. Stead R. T. Murdoch S. Devenish-Meares D. J. Morgan R. A. Smallwood (1991) ArticleTitleQuinidine single dose pharmacokinetics and pharmacodynamics are unaltered by omeprazole Aliment. Pharmacol. Ther. 5 523–531 Occurrence Handle1:CAS:528:DyaK38XltV2hsg%3D%3D Occurrence Handle1793783

    CAS  PubMed  Google Scholar 

  33. F. Pisani E. Perucca G. Primerano A. A. D'Agostino R. M. Petrelli A. Fazio G. Oteri R. Perri ParticleDi (1984) ArticleTitleSingle-dose kinetics of primidone in acute viral hepatitis Eur. J. Clin. Pharmacol. 27 465–469 Occurrence Handle10.1007/BF00549596 Occurrence Handle1:STN:280:DyaL2M7gtFKisw%3D%3D Occurrence Handle6519155

    Article  CAS  PubMed  Google Scholar 

  34. E. L. LeCluyse (2001) ArticleTitleHuman hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation Eur. J. Pharm. Sci. 13 343–368 Occurrence Handle1:CAS:528:DC%2BD3MXkt1yisLY%3D Occurrence Handle11408150 Occurrence Handle10.1016/S0928-0987(01)00135-X

    Article  CAS  PubMed  Google Scholar 

  35. G. Luo M. Cunningham S. Kim T. Burn J. Lin M. Sinz G. Hamilton C. Rizzo S. Jolley D. Gilbert A. Downey D. Mudra R. Graham K. Carroll J. Xie A. Madan A. Parkinson D. Christ B. Selling E. LeCluyse L. S. Gan (2002) ArticleTitleCYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes Drug Metab. Dispos. 30 795–804 Occurrence Handle1:CAS:528:DC%2BD38XltVGru78%3D Occurrence Handle12065438

    CAS  PubMed  Google Scholar 

  36. D. Roymans P. Annaert J. Houdt ParticleVan A. Weygers J. Noukens C. Sensenhauser J. Silva C. Looveren ParticleVan J. Hendrickx G. Mannens W. Meuldermans (2005) ArticleTitleExpression and induction potential of cytochromes P450 in human cryopreserved hepatocytes Drug Metab. Dispos. 33 1004–1016 Occurrence Handle10.1124/dmd.104.003046 Occurrence Handle1:CAS:528:DC%2BD2MXlslWqsLs%3D Occurrence Handle15802389

    Article  CAS  PubMed  Google Scholar 

  37. R. S. Obach J. G. Baxter T. E. Liston B. M. Silber B. C. Jones F. MacIntyre D. J. Rance P. Wastall (1997) ArticleTitleThe prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data J. Pharmacol. Exp. Ther. 283 46–58 Occurrence Handle1:CAS:528:DyaK2sXmslCltr0%3D Occurrence Handle9336307

    CAS  PubMed  Google Scholar 

  38. J. C. Gorski S. Vannaprasaht M. A. Hamman W. T. Ambrosius M. A. Bruce B. Haehner-Daniels S. D. Hall (2003) ArticleTitleThe effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity. [erratum appears in Clin. Pharmacol. Ther. 75: 249 (2004)] Clin. Pharmacol. Ther. 74 275–287 Occurrence Handle10.1016/S0009-9236(03)00187-5 Occurrence Handle1:CAS:528:DC%2BD3sXmvVKmtr8%3D Occurrence Handle12966371

    Article  CAS  PubMed  Google Scholar 

  39. M. F. Fromm D. Busse H. K. Kroemer M. Eichelbaum (1996) ArticleTitleDifferential induction of prehepatic and hepatic metabolism of verapamil by rifampin Hepatology 24 796–801 Occurrence Handle1:CAS:528:DyaK28XmvFOisbw%3D Occurrence Handle8855178

    CAS  PubMed  Google Scholar 

  40. N. Holtbecker M. F. Fromm H. K. Kroemer E. E. Ohnhaus H. Heidemann (1996) ArticleTitleThe nifedipine–rifampin interaction. Evidence for induction of gut wall metabolism [see comment] Drug Metab. Dispos. 24 1121–1123 Occurrence Handle1:CAS:528:DyaK28XmsVeit7s%3D Occurrence Handle8894514

    CAS  PubMed  Google Scholar 

  41. M. Ashton T. Gordi N. H. Trinh V. H. Nguyen D. S. Nguyen T. N. Nguyen X. H. Dinh M. Johansson D. C. Le (1998) ArticleTitleArtemisinin pharmacokinetics in healthy adults after 250, 500 and 1000 mg single oral doses Biopharm. Drug Dispos. 19 245–250 Occurrence Handle10.1002/(SICI)1099-081X(199805)19:4<245::AID-BDD99>3.0.CO;2-Z Occurrence Handle1:CAS:528:DyaK1cXjt1arsrk%3D Occurrence Handle9604124

    Article  CAS  PubMed  Google Scholar 

  42. K. Kubota E. S. Lo G. Huttinot P. H. Andersen H. I. Maibach (1994) ArticleTitlePlasma concentrations of betamethasone after topical application of betamethasone 17-valerate: comparison with oral administration Br. J. Clin. Pharmacol. 37 86–88 Occurrence Handle8148226

    PubMed  Google Scholar 

  43. M. Olling T. T. Mensinga D. M. Barends C. Groen O. A. Lake J. Meulenbelt (1999) ArticleTitleBioavailability of carbamazepine from four different products and the occurrence of side effects Biopharm. Drug Dispos. 20 19–28 Occurrence Handle10.1002/(SICI)1099-081X(199901)20:1<19::AID-BDD152>3.0.CO;2-Q Occurrence Handle1:CAS:528:DyaK1MXht1Srsb4%3D Occurrence Handle10086834

    Article  CAS  PubMed  Google Scholar 

  44. P. K.-F. Yeung J. W. Hubbard E. D. Korchinski K. K. Midha (1993) ArticleTitlePharmacokinetics of chlorpromazine and key metabolites Eur. J. Clin. Pharmacol. 45 563–569 Occurrence Handle10.1007/BF00315316 Occurrence Handle1:CAS:528:DyaK2cXkt1KitLc%3D Occurrence Handle8157044

    Article  CAS  PubMed  Google Scholar 

  45. P. J. Tiseo C. A. Perdomo L. T. Friedhoff (1998) ArticleTitleConcurrent administration of donepezil HCl and cimetidine: assessment of pharmacokinetic changes following single and multiple doses Br. J. Clin. Pharmacol. 46 IssueIDSuppl. I 25–29 Occurrence Handle1:CAS:528:DyaK1cXnsFCqsb0%3D Occurrence Handle9839762

    CAS  PubMed  Google Scholar 

  46. B. T. O'Sullivan D. J. Cutler G. E. Hunt C. Walters G. F. Johnson I. D. Caterson (1997) ArticleTitlePharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects Biol. Psychiatry 41 574–584 Occurrence Handle9046990

    PubMed  Google Scholar 

  47. E. E. Ohnhaus N. Brockmeyer P. Dylewicz H. Habicht (1987) ArticleTitleThe effect of antipyrine and rifampin on the metabolism of diazepam Clin. Pharmacol. Ther. 42 148–156 Occurrence Handle1:CAS:528:DyaL2sXlsVKrtrY%3D Occurrence Handle3608348 Occurrence Handle10.1038/clpt.1987.125

    Article  CAS  PubMed  Google Scholar 

  48. A. Biber H. Fischer A. Römer S. S. Chatterjee (1998) ArticleTitleOral bioavailability of hyperforin from hypericum extracts in rats and human volunteers Pharmacopsychiatry 31 IssueIDSuppl. 36–43 Occurrence Handle1:CAS:528:DyaK1cXlsFeis7Y%3D Occurrence Handle9684946

    CAS  PubMed  Google Scholar 

  49. G. Alván M. Orme L. Bertilsson R. Ekstrand L. Palmér (1975) ArticleTitlePharmacokinetics of indomethacin Clin. Pharmacol. Ther. 18 364–373 Occurrence Handle1100305

    PubMed  Google Scholar 

  50. J. X. Sun R. Niecestro G. Phillips J. Shen P. Lukacsko L. Friedhoff (2002) ArticleTitleComparative pharmacokinetics of lovastatin extended-release tablets and lovastatin immediate-release tablets in humans J. Clin. Pharmacol. 42 198–204 Occurrence Handle10.1177/00912700222011111 Occurrence Handle1:CAS:528:DC%2BD38XhsVWltL4%3D Occurrence Handle11831543

    Article  CAS  PubMed  Google Scholar 

  51. J. F. Rogers A. L. Morrison A. N. Nafziger C. L. Jones M. L. Rocci SuffixJr. J. S. Bertino SuffixJr (2002) ArticleTitleFlumazenil reduces midazolam-induced cognitive impairment without altering pharmacokinetics Clin. Pharmacol. Ther. 72 711–717 Occurrence Handle10.1067/mcp.2002.128866 Occurrence Handle1:CAS:528:DC%2BD3sXlt1Sisg%3D%3D Occurrence Handle12496752

    Article  CAS  PubMed  Google Scholar 

  52. D. Zhou Q. Zhang W. Lu Q. Xia S. Wei (1998) ArticleTitleSingle- and multiple-dose pharmacokinetic comparison of a sustained-release tablet and conventional tablets of naproxen in healthy volunteers J. Clin. Pharmacol. 38 625–629 Occurrence Handle1:CAS:528:DyaK1cXltleis7w%3D Occurrence Handle9702847

    CAS  PubMed  Google Scholar 

  53. P. Reidenberg P. Glue C. R. Banfield R. D. Colucci J. W. Meehan E. Radwanski P. Mojavarian C. C. Lin J. Nezamis M. Guillaume M. B. Affrime (1995) ArticleTitleEffects of felbamate on the pharmacokinetics of phenobarbital Clin. Pharmacol. Ther. 58 279–287 Occurrence Handle10.1016/0009-9236(95)90244-9 Occurrence Handle1:CAS:528:DyaK2MXpsVSltL4%3D Occurrence Handle7554701

    Article  CAS  PubMed  Google Scholar 

  54. E. Spaans M. W. Heuvel Particlevan den P. G. Schnabel P. A. M. Peeters U. G. Chin-Kon-Sung E. P. H. Colbers J. M. A. Sitsen (2002) ArticleTitleConcomitant use of mirtazapine and phenytoin: a drug–drug interaction study in healthy male subjects Eur. J. Clin. Pharmacol. 58 423–429 Occurrence Handle1:CAS:528:DC%2BD38XntFensbg%3D Occurrence Handle12242602

    CAS  PubMed  Google Scholar 

  55. T. Hatanaka (2000) ArticleTitleClinical pharmacokinetics of pravastatin: mechanisms of pharmacokinetic events Clin. Pharmacokinet. 39 397–412 Occurrence Handle10.2165/00003088-200039060-00002 Occurrence Handle1:CAS:528:DC%2BD3MXotlaltw%3D%3D Occurrence Handle11192473

    Article  CAS  PubMed  Google Scholar 

  56. M. C. Meyer A. B. Straughn R. M. Mhatre V. P. Shah R. L. Williams L. J. Lesko (1998) ArticleTitleLack of in vivo/in vitro correlations for 50 mg and 250 mg primidone tablets Pharm. Res. 15 1085–1089 Occurrence Handle1:CAS:528:DyaK1cXkvVWgurs%3D Occurrence Handle9688064

    CAS  PubMed  Google Scholar 

  57. S. Yasuda Y. Horai Y. Tomono H. Nakai C. Yamato K. Manabe K. Kobayashi K. Chiba T. Ishizaki (1995) ArticleTitleComparison of the kinetic disposition and metabolism of E3810, a new proton pump inhibitor, and omeprazole in relation to S-mephenytoin 4′-hydroxylation status Clin. Pharmacol. Ther. 58 143–154 Occurrence Handle1:CAS:528:DyaK2MXosF2ms7s%3D Occurrence Handle7648764

    CAS  PubMed  Google Scholar 

  58. R. E. Polk D. F. Brophy D. S. Israel R. Patron B. M. Sadler G. E. Chittick W. T. Symonds Y. Lou D. Kristoff D. S. Stein (2001) ArticleTitlePharmacokinetic interaction between amprenavir and rifabutin or rifampin in healthy males Antimicrob. Agents Chemother. 45 502–508 Occurrence Handle10.1128/AAC.45.2.502-508.2001 Occurrence Handle1:CAS:528:DC%2BD3MXmsVGlug%3D%3D Occurrence Handle11158747

    Article  CAS  PubMed  Google Scholar 

  59. P. Ott L. Ranek M. A. Young (1998) ArticleTitlePharmacokinetics of troglitazone, a PPAR-gamma agonist, in patients with hepatic insufficiency Eur. J. Clin. Pharmacol. 54 567–571 Occurrence Handle10.1007/s002280050514 Occurrence Handle1:CAS:528:DyaK1cXmt12gur4%3D Occurrence Handle9832300

    Article  CAS  PubMed  Google Scholar 

  60. P. Robertson SuffixJr. E. T. Hellriegel S. Arora M. Nelson (2002) ArticleTitleEffect of modafinil at steady state on the single-dose pharmacokinetic profile of warfarin in healthy volunteers J. Clin. Pharmacol. 42 205–214 Occurrence Handle1:CAS:528:DC%2BD38XhsVWltL8%3D Occurrence Handle11831544

    CAS  PubMed  Google Scholar 

  61. M. E. Krecic-Shepard C. R. Barnas J. Slimko J. B. Schwartz (2000) ArticleTitleFaster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil Clin. Pharmacol. Ther. 68 286–292 Occurrence Handle1:CAS:528:DC%2BD3cXntFOgtbk%3D Occurrence Handle11014410

    CAS  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. Collen M. Masimirembwa

    Present address: African Institute of Biomedical Science and Technology, P.O. Box 2294, Harare, Zimbabwe

Authors and Affiliations

  1. DMPK & Bioanalytical Chemistry, AstraZeneca R&D Mölndal, 431 83, Mölndal, Sweden

    Kajsa P. Persson, Susanne Ekehed, E. S. Mareike Lutz, Collen M. Masimirembwa & Tommy B. Andersson

  2. Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska University Hospital, Huddinge, 141 86, Stockholm, Sweden

    Kajsa P. Persson

  3. Molecular Pharmacology, AstraZeneca R&D Mölndal, 431 83, Mölndal, Sweden

    Charlotta Otter & Jane McPheat

  4. Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, 171 77, Stockholm, Sweden

    Tommy B. Andersson

Authors
  1. Kajsa P. Persson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susanne Ekehed
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Charlotta Otter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. S. Mareike Lutz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jane McPheat
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Collen M. Masimirembwa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tommy B. Andersson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kajsa P. Persson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Persson, K.P., Ekehed, S., Otter, C. et al. Evaluation of Human Liver Slices and Reporter Gene Assays as Systems for Predicting the Cytochrome P450 Induction Potential of Drugs in Vivo in Humans. Pharm Res 23, 56–69 (2006). https://doi.org/10.1007/s11095-005-8812-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-005-8812-5

Key Words

Search

Navigation